Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma. Cui G, Zhou Y, Liao W, Cossu E, et al. Cancer Res 2025 Sep 12. doi: 10.1158/0008-5472.CAN-25-1615.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cui G, Zhou Y, Liao W, Cossu E, et al. Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma. Cancer Res 2025 Sep 12. doi: 10.1158/0008-5472.CAN-25-1615.
PMID: 40939191